RespiTrend, Inc., Developing Noninvasive Devices for Blood Propofol and Blood Glucose Monitoring
RespiTrend, Inc. (“RTI”) is a medical technology company which is raising capital to advance commercialization of two technology platforms, PROPOTREND™ and GLUCOTREND™ for the healthcare industry. - January 28, 2016
Press Releases 1 - 1 of 1